Rogers Communications Inc. (RCI-A.TO)
CAD 48.02
(-0.99%)
CAD 48.02
(-0.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.22 Billion | 4.49 Billion | 4.16 Billion | 4.32 Billion | 4.52 Billion | 4.28 Billion |
| Net Income | 849 Million | 1.68 Billion | 1.55 Billion | 1.59 Billion | 2.04 Billion | 2.05 Billion |
| Depreciation & Amortization | 4.19 Billion | 2.63 Billion | 2.65 Billion | 2.69 Billion | 2.56 Billion | 2.26 Billion |
| Deferred income taxes | 517 Million | 609 Million | 569 Million | 580 Million | 712 Million | 758 Million |
| Stock-based compensation | 115 Million | 143 Million | 118 Million | 96 Million | 103 Million | 144 Million |
| Change in working capital | -627 Million | -152 Million | 37 Million | -333 Million | -138 Million | -114 Million |
| Other non-cash items | 2.05 Billion | 1.2 Billion | 851 Million | 1 Billion | 598 Million | 472 Million |
| Investing Cash Flow | -20.2 Billion | -3.26 Billion | -6.13 Billion | -2.55 Billion | -4.61 Billion | -2.94 Billion |
| Investments in PPE | -4.11 Billion | -3.12 Billion | -2.84 Billion | -2.36 Billion | -2.86 Billion | -2.84 Billion |
| Acquisitions | -16.21 Billion | -9 Million | -3.4 Billion | -103 Million | -1.73 Billion | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 131 Million | -132 Million | 113 Million | -86 Million | -14 Million | -100 Million |
| Financing Cash Flow | 2.47 Billion | 11.35 Billion | 203 Million | 227 Million | 175 Million | -933 Million |
| Debt repayment | -11.84 Billion | -316 Million | -269 Million | -213 Million | -167 Million | -823 Million |
| Dividends payments | -960 Million | -1.01 Billion | -1.01 Billion | -1.01 Billion | -1.01 Billion | -988 Million |
| Common Stock Repurchased | - | - | - | - | -655 Million | - |
| Common Stock Issuance | - | - | - | - | 2.21 Billion | - |
| Other Financing Activities | 15.27 Billion | 12.68 Billion | 1.48 Billion | 1.45 Billion | -201 Million | 878 Million |
| Accounts receivables | -362 Million | -201 Million | -78 Million | 455 Million | -174 Million | -133 Million |
| Accounts payables | -399 Million | -93 Million | 146 Million | -1.93 Billion | 167 Million | 97 Million |
| Inventory | -4 Million | 98 Million | -56 Million | -19 Million | 7 Million | -31 Million |
| Other working capital | 138 Million | 44 Million | 25 Million | 1.17 Billion | -138 Million | -47 Million |
| Cash at beginning of period | 13.3 Billion | 715 Million | 2.48 Billion | 494 Million | 405 Million | -6 Million |
| Cash at end of period | 800 Million | 13.3 Billion | 715 Million | 2.48 Billion | 494 Million | 405 Million |
| Capital Expenditure | -4.11 Billion | -3.12 Billion | -2.84 Billion | -2.36 Billion | -2.86 Billion | -2.84 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -12.5 Billion | 12.58 Billion | -1.76 Billion | 1.99 Billion | 89 Million | 411 Million |
| Free Cash Flow | 1.1 Billion | 1.37 Billion | 1.31 Billion | 1.95 Billion | 1.65 Billion | 1.44 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 526 Million | 394 Million | 256 Million | 328 Million | 849 Million | -99 Million |
| Depreciation & Amortization | 1.17 Billion | 1.15 Billion | 1.16 Billion | 1.18 Billion | 4.19 Billion | 1.17 Billion |
| Deferred income taxes | 201 Million | 134 Million | 79 Million | 194 Million | 517 Million | 111 Million |
| Stock-based compensation | - | -13 Million | -27 Million | 125 Million | 115 Million | -32 Million |
| Change in working capital | 200 Million | -120 Million | -289 Million | -369 Million | -627 Million | 185 Million |
| Other non-cash items | -204 Million | 511 Million | 573 Million | 532 Million | 2.05 Billion | 560 Million |
| Investing Cash Flow | -1.08 Billion | -1.43 Billion | -1.06 Billion | -224 Million | -20.2 Billion | -950 Million |
| Investments in PPE | -1.01 Billion | -1 Billion | -1.07 Billion | -963 Million | -4.11 Billion | -1.12 Billion |
| Acquisitions | - | -380 Million | -95 Million | 786 Million | -16.21 Billion | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.08 Billion | -49 Million | 100 Million | -47 Million | 131 Million | 177 Million |
| Financing Cash Flow | -461 Million | -347 Million | -150 Million | -2.88 Billion | 2.47 Billion | 1.36 Billion |
| Debt repayment | -251 Million | -180 Million | -84 Million | -5.39 Billion | -11.84 Billion | -2.71 Billion |
| Dividends payments | -186 Million | -182 Million | -190 Million | -191 Million | -960 Million | -264 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -24 Million | 15 Million | -44 Million | 2.7 Billion | 15.27 Billion | 4.34 Billion |
| Accounts receivables | -44 Million | -56 Million | 106 Million | -182 Million | -362 Million | -186 Million |
| Accounts payables | 243 Million | -124 Million | - | -340 Million | -399 Million | 331 Million |
| Inventory | 41 Million | -7 Million | -50 Million | 6 Million | -4 Million | 83 Million |
| Other working capital | 203 Million | -131 Million | 91 Million | 147 Million | 138 Million | -43 Million |
| Cash at beginning of period | 451 Million | 764 Million | 800 Million | 2.52 Billion | 13.3 Billion | 359 Million |
| Cash at end of period | 802 Million | 451 Million | 764 Million | 800 Million | 800 Million | 2.52 Billion |
| Capital Expenditure | -1.01 Billion | -1 Billion | -1.07 Billion | -963 Million | -4.11 Billion | -1.12 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 351 Million | -313 Million | -36 Million | -1.72 Billion | -12.5 Billion | 2.16 Billion |
| Free Cash Flow | 883 Million | 463 Million | 109 Million | 416 Million | 1.1 Billion | 627 Million |
HITECHCORP
CEEB3
JYOTIRES
NSB
INSECTICID
TCNT